Skip to Content
Merck
All Photos(2)

Key Documents

HT110216

Sigma-Aldrich

Eosin Y Solution, Aqueous

Sign Into View Organizational & Contract Pricing


About This Item

UNSPSC Code:
41116124
NACRES:
NA.47
Pricing and availability is not currently available.

form

solution

Quality Level

shelf life

Expiry date on the label.

IVD

for in vitro diagnostic use

concentration

0.5 % (w/v) in water

application(s)

hematology
histology

storage temp.

room temp

Looking for similar products? Visit Product Comparison Guide

Application

General purpose cytoplasmic counterstain. Used with hematoxylin and eosin staining.

Other Notes

Certified Eosin Y, 0.5% (w/v) in water. Not acidified.

Storage Class Code

10 - Combustible liquids

WGK

WGK 2

Flash Point(F)

Not applicable

Flash Point(C)

Not applicable

Personal Protective Equipment

dust mask type N95 (US), Eyeshields, Gloves

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Senna Staessens et al.
Haematologica, 105(2), 498-507 (2019-05-03)
Ischemic stroke is caused by a thromboembolic occlusion of cerebral arteries. Treatment is focused on fast and efficient removal of the occluding thrombus, either via intravenous thrombolysis or via endovascular thrombectomy. Recanalization, however, is not always successful and factors contributing
Frederik Denorme et al.
Blood, 127(19), 2337-2345 (2016-03-02)
Rapid vascular recanalization forms the basis for successful treatment of cerebral ischemia. Currently, tissue plasminogen activator (t-PA) is the only approved thrombolytic drug for ischemic stroke. However, t-PA does not always result in efficient thrombus dissolution and subsequent blood vessel
Kenneth C Valkenburg et al.
Oncotarget, 8(46), 80265-80277 (2017-11-09)
Prostate cancer is the most diagnosed non-skin cancer in the US and kills approximately 27,000 men per year in the US. Additional genetic mouse models are needed that recapitulate the heterogeneous nature of human prostate cancer. The Wnt/beta-catenin signaling pathway
Vincent W Yang et al.
Molecular cancer research : MCR, 17(1), 165-176 (2018-08-16)
Krüppel-like factor 4 (KLF4), a zinc finger transcription factor, regulates homeostasis of the intestinal epithelium. Previously, it was reported that KLF4 functions as a tumor suppressor in colorectal cancer. Here, evidence demonstrates that KLF4 mitigates the development and progression of
Kenneth C Valkenburg et al.
The Prostate, 74(15), 1506-1520 (2014-09-02)
Wnt/β-catenin signaling is important for prostate development and cancer in humans. Activation of this pathway in differentiated luminal cells of mice induces high-grade prostate intraepithelial neoplasia (HGPIN). Though the cell of origin of prostate cancer has yet to be conclusively

Questions

  1. What are the components of Eosin Y solution (cat# HT110216)? Is it made out of Eosin Y disodium salt (C20H6Br4Na2O5) or Eosin Y (C20H6Br4O5)?

    1 answer
    1. Eosin Y used to formulate Eosin Y aqueous is in the form of the disodium salt. The free acid has very limited solubility in water, generally around 0.08%. The free acid is sometimes referred to as spirit-soluble, as the dye has somewhat higher solubilities in alcohol or alcohol.

      Helpful?

Reviews

No rating value

Active Filters

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service